These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10204711)

  • 1. A simplified and standardized neutralization enzyme immunoassay for the quantification of measles neutralizing antibody.
    Lee MS; Cohen B; Hand J; Nokes DJ
    J Virol Methods; 1999 Mar; 78(1-2):209-17. PubMed ID: 10204711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance for epidemiological studies anti-measles antibody detection examined by enzyme immunoassay (EIA) and plaque reduction neutralization test (PRNT).
    Siennicka J; Częścik A; Trzcińska A
    Przegl Epidemiol; 2014; 68(3):417-20, 527-9. PubMed ID: 25394302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of an automatable focus reduction neutralisation test for the detection of measles virus antibodies using imaging analysis.
    Terletskaia-Ladwig E; Enders G; Meier S; Dietz K; Enders M
    J Virol Methods; 2011 Dec; 178(1-2):124-8. PubMed ID: 21939689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a new neutralization test for measles virus.
    Fujino M; Yoshida N; Kimura K; Zhou J; Motegi Y; Komase K; Nakayama T
    J Virol Methods; 2007 Jun; 142(1-2):15-20. PubMed ID: 17320979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody.
    Ratnam S; Gadag V; West R; Burris J; Oates E; Stead F; Bouilianne N
    J Clin Microbiol; 1995 Apr; 33(4):811-5. PubMed ID: 7790442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity.
    Haralambieva IH; Ovsyannikova IG; Vierkant RA; Poland GA
    Clin Vaccine Immunol; 2008 Jul; 15(7):1054-9. PubMed ID: 18463223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization enzyme-linked immunosorbent assay for evaluation of immunity to measles virus.
    Nates SV; Rey GY; Giordano MO; Depetris AR; Boshell J
    Viral Immunol; 1995; 8(1):47-52. PubMed ID: 8546804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a commercial enzyme immunoassay with plaque reduction neutralization for maternal and infant measles antibody measurement.
    Gonçalves G; Cutts F; Forsey T; Andrade HR
    Rev Inst Med Trop Sao Paulo; 1999; 41(1):21-6. PubMed ID: 10436666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a tissue-culture-based enzyme-immunoassay method for the quantitation of anti-vaccinia-neutralizing antibodies in human sera.
    Eyal O; Olshevsky U; Lustig S; Paran N; Halevy M; Schneider P; Zomber G; Fuchs P
    J Virol Methods; 2005 Dec; 130(1-2):15-21. PubMed ID: 16024096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles Foci Reduction Neutralization Test (FRNT).
    Santibanez S; Mankertz A
    Methods Mol Biol; 2024; 2808():209-224. PubMed ID: 38743373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of measles IgG enzyme immunoassays (EIA) versus plaque reduction neutralization test (PRNT) for measuring measles serostatus: a systematic review of head-to-head analyses of measles IgG EIA and PRNT.
    Lutz CS; Hasan AZ; Bolotin S; Crowcroft NS; Cutts FT; Joh E; Loisate S; Moss WJ; Osman S; Hayford K
    BMC Infect Dis; 2023 May; 23(1):367. PubMed ID: 37259032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a high-throughput assay for measuring serum neutralizing antibody against enterovirus 71.
    Huang ML; Chiang PS; Luo ST; Liou GY; Lee MS
    J Virol Methods; 2010 Apr; 165(1):42-5. PubMed ID: 20036286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison and evaluation of enzyme-linked immunization assay kits with plague reduction neutralization test for detection of measles IgG antibody].
    Mao NY; Zhu Z; Jiang XH
    Zhongguo Yi Miao He Mian Yi; 2009 Jun; 15(3):215-8. PubMed ID: 20084884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a high-throughput assay to measure measles neutralizing antibodies.
    Alvarado-Facundo E; Audet S; Moss WJ; Beeler JA
    PLoS One; 2019; 14(8):e0220780. PubMed ID: 31415584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.
    Cohen BJ; Doblas D; Andrews N
    Vaccine; 2008 Nov; 26(50):6392-7. PubMed ID: 18834911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays.
    Mauldin J; Carbone K; Hsu H; Yolken R; Rubin S
    J Clin Microbiol; 2005 Sep; 43(9):4847-51. PubMed ID: 16145156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization Assay for Chikungunya Virus Infection: Plaque Reduction Neutralization Test.
    Azami NA; Moi ML; Takasaki T
    Methods Mol Biol; 2016; 1426():273-82. PubMed ID: 27233280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of antibodies against measles antigen in institutionalized patients with severe motor and intellectual disability].
    Machida Y; Yamamoto J; Yano Y; Yano T
    Kansenshogaku Zasshi; 2008 Jul; 82(4):328-34. PubMed ID: 18697485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of IgM antibodies specific for measles virus by capture and indirect enzyme immunoassays.
    Arista S; Ferraro D; Cascio A; Vizzi E; di Stefano R
    Res Virol; 1995; 146(3):225-32. PubMed ID: 7481095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [EIA-IgG antibody measles prevention level estimated from measles neutralizing, particle agglutination and hemagglutination-inhibition antibody titer].
    Takayama N; Saika S; Ichinohe S
    Kansenshogaku Zasshi; 2009 Sep; 83(5):519-24. PubMed ID: 19860253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.